Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
Abroad (travel likely)RecruitingPHASE4
Conditions
Hepatic Encephalopathy · Cirrhosis, Liver · Portal Hypertension · Liver Diseases · Pathological Processes
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Universitaire Ziekenhuizen Leuven, Leuven, Belgium
Contact: Study coordinator (Frederik Nevens, prof. dr.)Academic Medical Centre, Amsterdam, Netherlands
Contact: Study coordinator (Bart Takkenberg, dr.)University Medical Center Groningen, Groningen, Netherlands
Contact: Study coordinator (F.J.C. Cuperus, Dr.)Leiden University Medical Center, Leiden, Netherlands
Contact: Study coordinator (M. Coenraad, Dr.)Radboud University, Nijmegen, Netherlands
Contact: Study coordinator (E.T.T.L. Tjwa, Dr.)Erasmus Medical Center, Rotterdam, Netherlands
Contact: Study coordinator (S. Coenen, Drs.)
Study leads
Bart Takkenberg, MD, PhD
Principal Investigator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)